![Sung Lee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sung Lee
Financieel Directeur/CFO bij CYTOKINETICS, INCORPORATED
Vermogen: 2 M $ op 31-05-2024
Profiel
Sung H.
Lee's career history includes current and former positions as well as education.
Currently, Mr. Lee is the Chief Financial Officer & Executive Vice President at Cytokinetics, Inc. Previously, Mr. Lee held positions at Gilead Sciences, Inc. as Vice President-Investor Relations from 2005 to 2019, Sangamo Therapeutics, Inc. as Chief Financial Officer & Executive Vice President from 2019 to 2021, MorphoSys AG as Chief Financial Officer from 2021 to 2023, and Vir Biotechnology, Inc. as Chief Financial Officer, Secretary & Executive VP from 2023 to 2024.
Mr. Lee obtained a graduate degree from the University of Southern California and an undergraduate degree from the University of California, Irvine.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
31-05-2024 | 34 684 ( 0.03% ) | 2 M $ | 31-05-2024 | |
VIR BIOTECHNOLOGY, INC.
0.01% | 01-04-2024 | 10 617 ( 0.01% ) | 109 037 $ | 31-05-2024 |
Actieve functies van Sung Lee
Bedrijven | Functie | Begin |
---|---|---|
CYTOKINETICS, INCORPORATED | Financieel Directeur/CFO | 08-05-2024 |
Eerdere bekende functies van Sung Lee
Bedrijven | Functie | Einde |
---|---|---|
VIR BIOTECHNOLOGY, INC. | Financieel Directeur/CFO | 03-05-2024 |
MORPHOSYS AG | Financieel Directeur/CFO | 17-03-2023 |
SANGAMO THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-02-2021 |
GILEAD SCIENCES, INC. | Investor Relations Contact | 31-10-2019 |
Opleiding van Sung Lee
University of California, Irvine | Undergraduate Degree |
University of Southern California | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
SANGAMO THERAPEUTICS, INC. | Health Technology |
MORPHOSYS AG | Health Technology |
VIR BIOTECHNOLOGY, INC. | Health Technology |
CYTOKINETICS, INCORPORATED | Health Technology |